CLASS II Drug recall · Reported 13 Aug 2014 · FDA Enforcement Report
Lipo 8 Injection USP 200 mg/ml recalled by Medical Supply Liquidators
Medical Supply Liquidators is recalling Lipo 8 Injection USP 200 mg/ml, distributed nationwide in the US. The recall was initiated on 25 Jun 2014 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1530-2014
- FDA event ID
- 68626
- Recalling firm
- Medical Supply Liquidators, Clive, IA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 25 Jun 2014
- FDA classified
- 6 Aug 2014
- Reported
- 13 Aug 2014
- Type
- Voluntary: Firm initiated
- Customers notified by
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 25 Jun 2014 | Recall initiated by company | |
| 6 Aug 2014 | Classified by FDA | +42 days |
| 13 Aug 2014 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Lipo 8 Injection USP 200 mg/ml, packaged in 30 ml vials, Sterile, Manufactured by: CB Inc. for Sunshine Labs, www.sunshinelabs.us.
Where it was distributed
Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.
Questions about this recall
Is Lipo 8 Injection USP 200 mg/ml recalled?
Yes. Medical Supply Liquidators recalled Lipo 8 Injection USP 200 mg/ml on 25 Jun 2014. The recall is Class II and its status is Terminated. Recall number D-1530-2014.
Why was it recalled?
Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer
Which lots are affected?
All lot numbers and exp dates
Where was it sold?
Nationwide and Foriegn distribution was made to Canada, United Kingdom, Australia, Slovenia, Germany, Spain, Finland and Croatia.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Medical Supply Liquidators
All 15| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Vitamin B6 Pyridoxine HCL for Injection USP, 100 mg/ml recalled | Medical Supply Liquidators | Sterility | Nationwide |
| Drug | CLASS II | Vitamin B12 Cyanocobalamin with MIC Injection USP 1000 mcg/ml recalled | Medical Supply Liquidators | Sterility | Nationwide |
| Drug | CLASS II | Vitamin B12 Methylcobalamin recalled by Medical Supply Liquidators | Medical Supply Liquidators | Sterility | Nationwide |
| Drug | CLASS II | Vitamin B12 Cyanocobalamin Injection USP 1000 mcg/ml recalled | Medical Supply Liquidators | Sterility | Nationwide |
| Drug | CLASS II | MIC Injection USP, Sterile vial and vial recalled | Medical Supply Liquidators | Sterility | Nationwide |